A comparison of the efficacy and safety of buserelin vs danazol in the treatment of endometriosis. Protocol 310 Study Group.
Dawood
M Y
MY
University of Illinois, Chicago.
Spellacy
W N
WN
Dmowski
W P
WP
Gambrell
R D
RD
Greenblatt
R B
RB
Girard
Y
Y
Lemay
A
A
Mishell
D R
DR
Nagamani
M
M
Pepperell
R J
RJ
D000328:Adult; D002064:Buserelin / Q000009:adverse effects / Q000627:therapeutic use*; D002979:Climacteric / Q000187:drug effects; D002985:Clinical Protocols; D003613:Danazol / Q000009:adverse effects / Q000627:therapeutic use*; D004715:Endometriosis / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy*; D004958:Estradiol / Q000097:blood; D005260:Female; D005298:Fertility / Q000187:drug effects; D006801:Humans; D008598:Menstruation / Q000187:drug effects; D011245:Pregnadienes / Q000627:therapeutic use*; D012449:Safety
D011245:Pregnadienes; D004958:Estradiol; D003613:Danazol; D002064:Buserelin